Insulin Resistance, Obesity and the Metabolic Syndrome. Is there a Therapeutic Role for Endothelin-1 Antagonists?
Journal:
Current Vascular Pharmacology
Volume:
3
Page:
359-363
Author(s):
Sidney G. Shaw and P. Jane Boden
Endothelin and Oxidative Stress in the Vascular System
Journal:
Current Vascular Pharmacology
Volume:
3
Page:
365-367
Author(s):
David M. Pollock and Jennifer S. Pollock
Connective Tissue Remodeling: Cross-Talk between Endothelins and Matrix Metalloproteinases
Journal:
Current Vascular Pharmacology
Volume:
3
Page:
369-379
Author(s):
David Abraham, Markella Ponticos and Hideaki Nagase
Localisation of Endothelin-1 and its Receptors in Vascular Tissue as Seen at the Electron Microscopic Level
Journal:
Current Vascular Pharmacology
Volume:
3
Page:
381-392
Author(s):
Andrzej Loesch
Endothelin-1 and Human Platelets
Journal:
Current Vascular Pharmacology
Volume:
3
Page:
393-399
Author(s):
I. Anita Jagroop, Stella S. Daskalopoulou and Dimitri P. Mikhailidis
Erythropoietin in Heart Failure and Other Cardiovascular Diseases: Hematopoietic and Pleiotropic Effects
Journal:
Current Drug Targets - Cardiovascular & Hematological Disorders
Volume:
5
Page:
355-375
Author(s):
Antonis S. Manolis, Stylianos Tzeis, Kostas Triantafyllou, John Michaelidis, Ioannis Pyrros, Nikolaos Sakellaris, Athanasios Kranidis and Helen Melita
Role of PPAR-γ Agonist Thiazolidinediones in Treatment of Pre-Diabetic and Diabetic Individuals: A Cardiovascular Perspective
Journal:
Current Drug Targets - Cardiovascular & Hematological Disorders
Volume:
5
Page:
377-386
Author(s):
Rupal Dumasia, Kim A. Eagle, Eva Kline-Rogers, Niquole May, Leslie Cho and Debabrata Mukherjee
The Role of Renin Angiotensin System Blockade in the Treatment of Atrial Fibrillation
Journal:
Current Drug Targets - Cardiovascular & Hematological Disorders
Volume:
5
Page:
387-403
Author(s):
Polychronis Dilaveris, Georgios Giannopoulos, Andreas Synetos and Christodoulos Stefanadis
Will this be the End of the Anticoagulation Clinic for Patients with Atrial Fibrillation?
Journal:
Current Drug Targets - Cardiovascular & Hematological Disorders
Volume:
5
Page:
405-408
Author(s):
Andrew R.J. Mitchell
Clinical Aspects and Therapeutic Perspectives of Relaxin
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
5
Page:
403-410
Author(s):
D. Bani and M. Bigazzi